Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02470832Phase 1Completed
Phase 1, open-label, single-arm trial of basmisanil in Down syndrome, sponsored by Roche. Primary endpoints: Area under the plasma concentration-time curve from 0-t, Maximum observed plasma concentration and 1 more. Started May 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02470832.